Neuroblastoma (NB) is a common solid tumor in children and infants, the formation regression of which closely linked to tumor-host immune relationship. Stimulator interferon genes (STING) agonists, particularly cyclic dinucleotide (CDN), have promising potential NB therapy by generating innate adaptive stimulation, thus leading control. CDN delivery vivo challenging due negative charge, hydroph...